Gsa Capital Partners LLP Charles River Laboratories International, Inc. Transaction History

Gsa Capital Partners LLP

$1.35 Billion
Q4 2024

A detailed history of Gsa Capital Partners LLP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 1,310 shares of CRL stock, worth $202,919. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,310

Holding current value

$202,919

% of portfolio

0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$178.58 - $220.69 $233,939 - $289,103	1,310 New	1,310 $242,000
Q1 2020 May 12, 2020	SELL	$98.9 - $178.34 $1.64 Million - $2.96 Million	-16,572 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$126.05 - $152.76 $308,948 - $374,414	-2,451 Reduced 12.88%	16,572 $2.53 Million
Q3 2019 Nov 12, 2019	BUY	$125.07 - $143.67 $787,565 - $904,689	6,297 Added 49.48%	19,023 $2.52 Million
Q2 2019 Aug 06, 2019	SELL	$123.4 - $148.55 $465,711 - $560,627	-3,774 Reduced 22.87%	12,726 $1.81 Million
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $69,076 - $96,695	659 Added 4.16%	16,500 $2.4 Million
Q4 2018 Feb 12, 2019	BUY	$105.09 - $137.23 $374,540 - $489,087	3,564 Added 29.03%	15,841 $1.79 Million
Q3 2018 Nov 13, 2018	SELL	$112.11 - $134.54 $669,745 - $803,741	-5,974 Reduced 32.73%	12,277 $1.65 Million
Q2 2018 Aug 09, 2018	SELL	$102.37 - $117.25 $1.48 Million - $1.7 Million	-14,503 Reduced 44.28%	18,251 $2.05 Million
Q1 2018 May 11, 2018	BUY	$98.19 - $115.2 $80,810 - $94,809	823 Added 2.58%	32,754 $3.5 Million
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $878,461 - $1.03 Million	8,747 Added 37.73%	31,931 $3.5 Million
Q3 2017 Nov 20, 2017	BUY	$96.72 - $109.26 $2.24 Million - $2.53 Million	23,184	23,184 $2.5 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

51.4M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.88B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Charles River Laboratories International, Inc. Transaction History